Sorry!! The article you are trying to read is not available now.
BioTech/Pharma
Log In
Bussiness News
Politics And Regulation
Markets
The Economy
Editor's Pick
Trading And Investing
Stocks
ETFs
Fixed Income
Currencies
Earnings
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Hoofy & Boo
Radio
From The Buzz & Banter
Daily Recap
MV Education center
Video
t3 live subscriptions
Buzz And Banter
Cooper's Market Report
Techstrat Report
The Options Strategist
Minyanville
All Biotech/pharma Articles
Get
FREE MINYANVILLE
Newsletters & Alerts
Health Care Stocks in the Obamacare Era: The Story So Far
By
Howard Simons
Oct 31, 2013 12:00 pm
Health-care stocks have turned into higher-risk, lower-return investments, though instability may be the only constant as the full impact of the Affordable Care Act plays out.
Read this article
Pre-Market: Stocks Rise as Apple Earnings Loom; Merck Shares Fall as Singulair Goes Off Patent
Vincent Trivett
Pre-Market: What to Expect From Today's Apple iPad Event; September Job Gains Disappoint
Vincent Trivett
Obesity Drug Makers Vivus and Arena Just Can't Seem to Lighten Up
Kapitall
Questcor Pharmaceuticals Inc Traders See Short-Term Struggles Ahead
Schaeffer's Investment Research
Keep Calm and Invest On: Three Stocks to Survive the Government Shutdown
Kapitall
Health Care and Biotech ETFs Brace for Obamacare
David Fabian
Recommendations
Archive
March, 2018
February, 2018
January, 2018
December, 2017
November, 2017
October, 2017
September, 2017
August, 2017
July, 2017
June, 2017
May, 2017
April, 2017
TICKERS
PFE
MRK
JNJ
BMY
GSK
DNDN
GILD
VRTX
AMGN
LLY
ARNA
BIIB
See All Tickers »